Affiliation:
1. Unité de Bactériologie Moléculaire et Médicale, Institut Pasteur, 75724 Cedex 15, France
2. Institute of Microbiology and Immunology, 1000 Ljubljana, Slovenia
Abstract
ABSTRACT
Lyme borreliosis (LB) is a tick-borne spirochetal infection caused by three
Borrelia
species:
Borrelia afzelii
,
B. garinii
, and
B. burgdorferi
sensu stricto. LB evolves in two stages: a skin lesion called erythema migrans and later, different disseminated forms (articular, neurological, cardiac…). Previous research based on analysis of
ospC
sequences allowed the definition of 58 groups (divergence of <2% within a group and >8% between groups). Only 10 of these groups include all of the strains isolated from disseminated forms that are considered invasive. The aim of this study was to determine whether or not invasive strains belong to restricted
ospC
groups by testing human clinical strains isolated from disseminated forms. To screen for
ospC
genetic diversity, we used single-strand conformation polymorphism (SSCP) analysis. Previously known
ospC
sequences from 44 different strains were first tested, revealing that each
ospC
group had a characteristic SSCP pattern. Therefore, we studied 80 disseminated-form isolates whose
ospC
sequences were unknown. Of these, 28 (35%) belonged to previously known invasive groups. Moreover, new invasive groups were identified: six of
B. afzelii
, seven of
B. garinii
, and one of
B. burgdorferi
sensu stricto. This study confirmed that invasive strains are not distributed among all 69
ospC
groups but belong to only 24 groups. This suggests that OspC may be involved in the invasiveness of
B. burgdorferi
.
Publisher
American Society for Microbiology
Reference26 articles.
1. Assous, M., D. Postic, G. Paul, P. Nevot, and G. Baranton. 1993. Western blot analysis of sera from Lyme borreliosis patients according to the genomic species of the Borrelia strains used as antigens. Eur. J. Clin. Microbiol. Infect. Dis.12:261-268.
2. Baranton, G., D. Postic, I. Saint Girons, P. Boerlin, J.-C. Piffaretti, M. Assous, and P. A. D. Grimont. 1992. Delineation of Borrelia burgdorferi sensu stricto, Borrelia garinii sp. nov., and group VS461 associated with Lyme borreliosis. Int. J. Syst. Bacteriol.42:378-383.
3. Baranton, G., G. Seinost, G. Theodore, D. Postic, and D. Dykhuisen. 2001. Distinct levels of genetic diversity of Borrelia burgdorferi are associated with different aspects of pathogenicity. Res. Microbiol.149-156.
4. Caniça, M. M., F. Nato, L. Du Merle, J. C. Mazie, G. Baranton, and D. Postic. 1993. Monoclonal antibodies for identification of Borrelia afzelii sp. nov. associated with late cutaneous manifestations of Lyme borreliosis. Scand. J. Syst. Infect. Dis.25:441-448.
5. Dhôte, R., A. L. Basse-Guerineau, V. Beaumesnil, B. Christoforov, and M. Assous. 2000. Full spectrum of clinical, serological, and epidemiological features of complicated forms of Lyme borreliosis in the Paris, France, area. Eur. J. Clin. Microbiol. Infect. Dis.809-815.
Cited by
78 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献